BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
258 hedge funds and large institutions have $6.02B invested in Blueprint Medicines in 2023 Q4 according to their latest regulatory filings, with 60 funds opening new positions, 67 increasing their positions, 97 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
18% more funds holding
Funds holding: 219 → 258 (+39)
0.65% more ownership
Funds ownership: 106.67% → 107.32% (+0.65%)
31% less repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 97
Holders
258
Holding in Top 10
5
Calls
$131M
Puts
$102M
Top Buyers
| 1 | +$182M | |
| 2 | +$134M | |
| 3 | +$92M | |
| 4 |
Man Group
London,
United Kingdom
|
+$34.9M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$31.9M |
Top Sellers
| 1 | -$160M | |
| 2 | -$79.3M | |
| 3 | -$74.2M | |
| 4 |
Millennium Management
New York
|
-$69.7M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$51.2M |